Tag Archives: NDA

December, 2018

November, 2018

October, 2018

August, 2018

  • 2 August

    FDA Approves Progenics’ Azedra for the Treatment of Rare Adrenal Tumors

    NEW YORK, July 30, 2018 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc.(Nasdaq:PGNX) today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for AZEDRA (iobenguane I 131) 555 MBq/mL injection for intravenous use. AZEDRA, a radiotherapeutic, is indicated for the treatment of adult and pediatric patients 12 years and …

November, 2017

October, 2017

September, 2017

July, 2017

June, 2017